Advanced search
Publication Cover
Hematology Volume 25, 2020 - Issue 1
Submit an article Journal homepage
1,516
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia

Naglaa M. Hassana Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
,
Lobna A. Refaata Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
,
Ghada N. Ismaila Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
,
Mona Abdellateifb Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, EgyptCorrespondence[email protected]
,
Sayed A. Fadelc Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt
&
Rania S. AbdelAziza Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
Pages 405-413 | Published online: 15 Nov 2020

References

  • Mezei G, Sudan M, Izraeli S, et al. Epidemiology of childhood leukemia in the presence and absence of Down syndrome. Cancer Epidemiol. 2014;38:479–489.
  • Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukemia. Lancet. 2013;381:1943–1955.
  • Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–1552.
  • Ding LW, Sun QY, Tan KT, et al. Mutational landscape of pediatric acute lymphoblastic leukemia. Cancer Res. 2017;77:390–400.
  • Tasian SK, Hunger SP. Genomic characterization of pediatric acute lymphoblastic leukemia:an opportunity for precision medicine therapeutics. Br J Haematol. 2017;176:867–882.
  • Roberts KG, Mullighan CG. Genomics in acute lymphoblastic leukaemia: insights and treatment implications. Nat Rev Clin Oncol. 2015;12:344–357.
  • Liu XL, Liu HQ, Li J, et al. Role of epigenetic in leukemia: from mechanism to therapy. Chem Biol Interact. 2020;317:108963.
  • Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRs and siRNAs. Genes Dev. 2006;20:515–524.
  • de Oliveira JC, Brassesco MS, Scrideli CA, et al. MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer. 2012;59:599–604.
  • Carvalho de Oliveira J, Molinari Roberto G, Baroni M, et al. Mir dysregulation in childhood hematological cancer. Int J Mol Sci. 2018;19:2688.
  • Li X-J, Luo X-Q, Han B-W, et al. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. Br J Cancer. 2013;109:2189–2198.
  • Noman MZ, Buart S, Romero P, et al. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res. 2012;72(18):4629–4641.
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
  • Ultimo S, Martelli AM, Zauli G, et al. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia. J Cell Physiol. 2018 Aug;233(8):5642–5654.
  • Luan C, Yang Z, Chen B. The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy. Onco Targets Ther. 2015;8:2903.
  • Daniel AA, Attilio O, Robert H, et al. Revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Campana D. Minimal residual disease in acute lymphoblastic leukemia. Semin Hematol. 2009;46(1):100–106.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001 Dec;25(4):402–408.
  • Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–2741.
  • de Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res. 2012 Mar;36(3):293–298.
  • Schotte D, De Menezes RX, Moqadam FA, et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011 May;96(5):703–711.
  • Zhang H, Luo XQ, Zhang P, et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PloS One. 2009;4(11):e7826.
  • Xue Y, Yang X, Hu S, et al. A genetic variant in miR-100 is a protective factor of childhood acute lymphoblastic leukemia. Cancer Med. 2019 May;8(5):2553–2560.
  • Umerez M, Garcia-Obregon S, Martin-Guerrero I, et al. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia. Pharmacogenomics. 2018 Mar;19(4):361–373.
  • Mei Y, Li Z, Zhang Y, et al. Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia. Oncol Lett. 2017;14(6):8072–8077.
  • Rashed WM, Hamza MM, Matboli M, et al. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review. Cancer Metastasis Rev. 2019 Dec;38(4):771–782.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.